Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Celltrion Sweden AB
AB
Active
Org 5594852252
Gävlegatan 16, 113 30
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2024
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Celltrion Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
5M
7M
9M
8M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
Income statement
SEK thousands
Item
2024
Revenue
7 592
Staff expenses
—
EBITDA
779
Depreciation & amort.
−0
EBIT
779
Net financials
—
Profit before tax
779
Tax
−161
Net profit
618
Balance sheet
SEK thousands
Item
2024
Total assets
6 375
Equity
2 618
Long-term debt
0
Short-term debt
3 757
Total debt
3 757
Financial ratios
5-year trend
EBITDA margin
10.3%
This company
15.8%
Market median
-35% vs market
2024
2024
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
2024
2024
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
2024
2024
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
2024
2024
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
2024
2024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-12-31
View
PDF
More on Celltrion Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
